Allspring Global Investments’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-570
Closed -$1.63K 2216
2024
Q3
$1.63K Sell
570
-15,107
-96% -$42.4K ﹤0.01% 2283
2024
Q2
$43.9K Buy
15,677
+15,369
+4,990% +$41.2K ﹤0.01% 1988
2024
Q1
$875 Sell
308
-112
-27% -$381 ﹤0.01% 2242
2023
Q4
$1.72K Buy
420
+409
+3,718% +$1.15K ﹤0.01% 2113
2023
Q3
$34 Sell
11
-270,905
-100% -$861K ﹤0.01% 2775
2023
Q2
$899K Sell
270,916
-16,688
-6% -$49.3K ﹤0.01% 1444
2023
Q1
$613K Buy
287,604
+28,427
+11% +$70.2K ﹤0.01% 1545
2022
Q4
$697K Buy
259,177
+232,913
+887% +$679K ﹤0.01% 1515
2022
Q3
$85K Buy
26,264
+6,306
+32% +$28.5K ﹤0.01% 2143
2022
Q2
$97K Sell
19,958
-297,774
-94% -$1.83M ﹤0.01% 2077
2022
Q1
$2.42M Sell
317,732
-218,995
-41% -$1.69M ﹤0.01% 1405
2021
Q4
$4.96M Buy
+536,727
New +$5.7M 0.01% 1178

Other funds holding ORGO

Allspring Global Investments's ORGO Position: Q4 2024 in Review

Allspring Global Investments sold out of Organogenesis Holdings (ORGO) in Q4 2024, closing a stake of 570 shares — an estimated $1.63K sold.

Allspring Global Investments first reported a position in ORGO in Q4 2021 and held it in 12 quarters. The position peaked at $4.96M in Q4 2021. 120 funds tracked by Wall St. Rank hold ORGO as of Q4 2024.

  • Allspring Global Investments reported no remaining Organogenesis Holdings position as of Q4 2024 after selling out during the quarter.
  • Allspring Global Investments sold 570 Organogenesis Holdings shares in Q4 2024, an estimated $1.63K.
  • Allspring Global Investments first reported a position in Organogenesis Holdings in Q4 2021 and held it in 12 quarters.
  • Allspring Global Investments's Organogenesis Holdings position peaked at $4.96M in Q4 2021.
  • 120 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q4 2024.

Based on Allspring Global Investments's 13F filing for Q4 2024, filed 29 Jan 2025.